Site US1149 — Omaha, Nebraska

Site US1149 is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Site US1149 has participated in 1 clinical trials.

Therapeutic areas: Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Prostate Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US1149?

Site US1149 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US1149 conducted?

Site US1149 has 1 clinical trials on record. Their work covers Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Prostate Cancer.

Is Site US1149 accredited by Crixeo Health?

Site US1149 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US1149?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.